ReviewCNS drugsPublished
The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Review
- Venue
- CNS drugs
- Published
- Topic
- Clinical care
- Subject terms
- B-Lymphocytes; Animals; Humans; Multiple Sclerosis; Antigens, CD20; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity
- PubMed ID
- 40180777
- PubMed Central ID
- PMC12058931
- Open access
- Yes, open
- Added to directory
- Source checked